Code changes are coming soon to improve the Mapping Cancer Markers project. These changes will expand the Mapping Cancer Markers application's ability to deal with multi-label data sets and allow it to search for more specific signatures within them. Before the sarcoma data set, the project analyzed lung and ovarian cancer data sets, both of which have binary labels. Our lung cancer data set labelled samples as either "cancer" or "no cancer." Our ovarian data set labelled samples as short or long survival. The sarcoma data set is multi-label, and labels samples with seven different subtypes of sarcoma.